Key result
Drug-resistant temporal lobe epilepsy is linked to shortened baseline QTc and increased post-seizure heart rate.
Why the study?
Electroconductive disorders causing life-threatening arrhythmias are hypothesized to drive sudden unexpected death in epilepsy, but electrocardiographic parameters in drug-resistant temporal lobe epilepsy compared to healthy controls remain poorly understood.
Are there differences in electrocardiographic parameters between patients with drug-resistant temporal lobe epilepsy and healthy controls?
Case-Control (n=100)
Are there differences in electrocardiographic parameters between patients with drug-resistant temporal lobe epilepsy and healthy controls?
p-value: p=0.017
Patients with drug-resistant temporal lobe epilepsy exhibit shortened QTc intervals at baseline and increased heart rates with shortened RR intervals during seizures, which may relate to the risk of sudden unexpected death in epilepsy (SUDEP).
May warrant SUDEP risk monitoring in drug-resistant TLE; hypothesis-generating for ECG stratification, pending prospective trials.
Introduction: Sudden unexpected death in epilepsy (SUDEP) is the substantial cause of death in patients with epilepsy (PWE). Electroconductive disorders leading to life-threatening arrhythmia are mostly hypothesized to play a crucial role; however, there is paucity of knowledge in variable among the patients with drug-resistant temporal lobe epilepsy (TLE) compared to the healthy controls. Methods: The current case-control study has been conducted on 50 drug-resistant TLE patients as the cases and 50 age- and gender-matched healthy subjects selected from their first-degree family members. ECGs were taken when admitted at the hospital (base line), immediately after a seizure incidence and within an hour after the end of the seizure from the cases compared with a random ECG of the controls considering parameters including PR-, RR-, and corrected QT interval (QTc), P wave duration and heart rate (HR) variability. Results: Shorter corrected QTc interval was notified among the drug-resistant TLE patients compared to the controls (P-value=0.017) in the base line taken ECGs, while the assessments immediately after the seizure revealed significant differences in terms of RR-interval (P-value=0.005) and heart rate (P-value=0.005). Post-ictal ECGs did not differ between the groups (P-value>0.05). Conclusion: According to the findings of this study, shortened QTc interval at base line ECGs, shortened RR interval and increased HR during the seizure were the ECG elements affected in drug-resistant TLE patients; however, to generalize the outcomes, further studies are required.
No takes yet. Share an insight, caveat, or question.
Habibabadi et al. (2023) conducted a case-control in Drug-resistant temporal lobe epilepsy (n=100). Drug-resistant temporal lobe epilepsy vs. Healthy first-degree family members was evaluated on Baseline corrected QT interval (QTc) (p=0.017). Drug-resistant temporal lobe epilepsy was associated with a shortened baseline QTc interval (P=0.017), and shortened RR interval and increased heart rate immediately after a seizure (P=0.005).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: